Generation Xanax : doubling in children being treated for addiction
New figures reveal the rise of “generation Xanax” - with a doubling in young people being treated for addiction to anti-anxiety drugs.
The statistics from Public Health England show 315 cases in which those under the age of 18 were treated for problems with benzodiazepines - a class of drugs used to treat anxiety and insomnia.
They include the drug Alprazolam (better known as Xanax) where there was a six-fold rise in numbers treated.
Latest NHS figures suggest one in eight children has a mental health disorder, amid warnings of an “epidemic of anxiety”....